Nukkleus INC 8-K filings

Nukkleus Inc. has agreed to sell its subsidiary, Digital RFQ Limited, to Jamal Khurshid for £1,000, pending shareholder approval, as part of a strategic move to focus on the defense sector.

Nukkleus Inc. has announced a $10 million private placement with a single investor, priced above the market, to fund a strategic acquisition and for general corporate purposes.

Nukkleus Inc. has agreed to acquire a 51% controlling interest in Star 26 Capital, a defense acquisition company, for $15 million in cash and stock, plus warrants.

Nukkleus Inc. has entered into a standby equity purchase agreement with YA II PN, LTD., providing the company with access to up to $10 million in funding through the sale of common stock.

Nukkleus Inc. is investigating a discrepancy in the number of shares requested by DTCC following a reverse stock split, potentially leading to liability if the company is required to issue the requested shares.

Nukkleus Inc. has finalized a securities purchase agreement with ProETP DAC, issuing 138,556 shares for $246,145 to bolster its working capital.

Nukkleus Inc. received a delisting notice from Nasdaq for failing to meet minimum market value requirements and has amended a debt conversion agreement with X Group Fund of Funds.

Nukkleus Inc. has announced the resignation of three directors, the appointment of two new directors, several share issuances, and the sale of a subsidiary, all effective November 8, 2024.

Nukkleus, Inc. will implement a 1-for-8 reverse stock split effective October 24, 2024, to meet Nasdaq's minimum bid price requirement.

Nukkleus Inc. has announced a 1-for-8 reverse stock split and an increase in authorized shares to regain compliance with Nasdaq listing rules.

Nukkleus Inc. has terminated its General Services Agreements with Triton Capital Markets Ltd. and FXDirectDealer LLC, effective January 1, 2024, and confirmed no outstanding liabilities as of September 30, 2024.

Nukkleus Inc. has appointed a new CEO and two new directors, while also securing additional financing through a promissory note.

Nukkleus Inc. has received a delisting notification from Nasdaq due to the late filing of its quarterly report and ongoing non-compliance with several listing rules.

Nukkleus Inc. has entered into a financing agreement, securing a $515,500 loan with warrants and conversion options for the lender.

Nukkleus Inc. has announced the resignation of its CEO, Emil Assentato, and the immediate appointment of Jamal (Jamie) Khurshid as the new CEO, effective July 24, 2024.

Nukkleus Inc. has entered into a restructuring agreement, securing a $312,500 loan with warrants and a potential for further investment, while also agreeing to restructure its board and consider the sale of a subsidiary.

Nukkleus Inc. has reached a settlement with Silverback Capital Corporation to resolve $1.1 million in outstanding liabilities by issuing shares of common stock.

Nukkleus Inc. reports the immediate resignation of two board members, Derek Campbell and Brian Ferrier, effective May 24, 2024.

Nukkleus Inc. has received a delisting notification from Nasdaq due to the failure to file its quarterly report and non-compliance with several listing rules, including minimum bid price and market value requirements.

Nukkleus Inc. has received notifications from Nasdaq for failing to meet minimum market value requirements for continued listing, giving them until November 12, 2024, to regain compliance.

Nukkleus Inc. has received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, placing its listing at risk.

Nukkleus Inc. reports the resignation of its CFO, Tony Porcheron, and the appointment of Emil Assentato as interim CFO, effective February 12, 2024.

Nukkleus Inc. has appointed Colonel Derek Campbell to its Board of Directors, signaling a strategic move to strengthen its presence in emerging markets, particularly Africa.

Nukkleus Inc. has signed a Memorandum of Understanding to potentially increase its stake in Jacobi Asset Management, the sponsor of Europe's first regulated Bitcoin spot ETF, to approximately 20%.

Nukkleus Inc. has received confirmation from Nasdaq that it has cured its prior listing deficiency and will continue to trade on the exchange.